Skip to main content
Ocumension Therapeutics logo

Ocumension Therapeutics — Investor Relations & Filings

Ticker · 1477 ISIN · KYG674111011 LEI · 5493000USURI3SIL4Z85 HKEX Manufacturing
Open in API
Filings indexed 460 across all filing types
Latest filing 2020-07-09 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 1477

About Ocumension Therapeutics

http://www.ocumension.com

Ocumension Therapeutics is an ophthalmic pharmaceutical platform company dedicated to the research, development, and commercialization of first-in-class or best-in-class therapeutics. The company focuses on providing comprehensive treatment solutions for Chinese patients suffering from ocular diseases. Ocumension has established a complete ophthalmic drug product line, currently holding 20 drug assets covering both anterior and posterior segments of the eye. Its portfolio addresses major conditions such as chronic non-infectious uveitis, infective and allergic conjunctivitis, and diabetic macular edema. The company employs a strategy combining continuous scientific innovation, independent R&D, and strategic alliances to sustain the supply of innovative products across the ophthalmology field.

Recent filings

Filing Released Lang Actions
ANNOUNCEMENT OF OFFER PRICE AND ALLOTMENT RESULTS
Regulatory Filings Classification · 95% confidence The document is an official announcement from the Hong Kong Stock Exchange (HKEX) regarding the 'IPO Allotment Results' for Ocumension Therapeutics. It provides links to various PDF files containing the results of share applications (White/Yellow forms, eIPO). Since this is a regulatory announcement regarding the outcome of an initial public offering process and does not fit into specific categories like 'Share Issue' (which usually refers to secondary offerings or capital changes) or 'Report Publication', it is best classified as a general regulatory filing.
2020-07-09 English
GREEN APPLICATION FORM
Capital/Financing Update Classification · 95% confidence The document is an application form for a Hong Kong public offering of shares by Ocumension Therapeutics. It includes detailed information about the global offering, number of shares, offer price, regulatory disclaimers, and instructions for applying for shares. It references the prospectus dated June 29, 2020, and contains terms and conditions related to the share offering. This is clearly related to a capital raising event and the issuance of new shares to the public. The document is not a report, transcript, or announcement of voting results, but rather a form used in the capital issuance process. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2020-06-29 English
YELLOW APPLICATION FORM
Share Issue/Capital Change Classification · 100% confidence The document is an application form related to the issuance and subscription of shares in Ocumension Therapeutics, referencing a prospectus dated June 29, 2020. It includes detailed instructions on how to apply for shares, payment methods, and legal disclaimers about the offer. There is no indication that this is a financial report, earnings release, or management discussion. Instead, it is clearly related to a share issuance process, specifically the public offering of shares. This fits the category of a Share Issue/Capital Change announcement, as it pertains to the issuance of new shares to the public and the application process for those shares.
2020-06-29 English
WHITE APPLICATION FORM
Capital/Financing Update Classification · 95% confidence The document is an application form related to the issuance of Hong Kong Offer Shares for Ocumension Therapeutics, referencing a prospectus dated June 29, 2020. It contains detailed instructions on how to apply for shares, payment details, and legal disclaimers about the offer. This is clearly related to a capital raising event, specifically a public offering of shares. The document is not a report, financial statement, or announcement of results, but rather a form used by investors to subscribe for shares. Therefore, it fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2020-06-29 English
GLOBAL OFFERING
Capital/Financing Update Classification · 95% confidence The document is a detailed prospectus for a global offering of shares by Ocumension Therapeutics, including information about the number of shares offered, offer price, underwriting arrangements, expected timetable for the offering, and regulatory disclaimers. It is clearly related to a capital raising event, specifically an initial public offering (IPO) or share issuance. The content focuses on the offering details, subscription process, and related financial terms, which aligns with announcements or updates about capital structure changes or fundraising activities. It is not a financial report, earnings release, or management discussion, nor is it a regulatory filing or announcement of voting results. Therefore, the document fits best under the category of Capital/Financing Update (CAP). The document length and detail confirm it is not a brief announcement but a full prospectus, supporting a high confidence classification.
2020-06-29 English
GLOBAL OFFERING
Capital/Financing Update Classification · 95% confidence The document is an announcement related to a Global Offering of shares by Ocumension Therapeutics, including details about the number of shares offered, offer price, application procedures, underwriting, and listing information. It is a public announcement providing information about the share issuance and listing process, not a financial report or earnings release. It does not contain financial statements or management discussion but focuses on the capital raising event and share issuance details. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial and contains detailed offering information, consistent with a capital raising announcement rather than a brief notice or regulatory filing.
2020-06-29 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.